Cryo-Cell International is the first private cord blood bank to separate and store stem cells.

In January 1997, the Company's stock began trading on the NASDAQ Small Cap market under symbol CCEL.

In July 1998, a jury in California Superior Court in San Francisco awarded Cryo-Cell $1,050,000 for the University's breach of contract and a $120,000 judgment against the University and David Harris personally for improperly transferring customer lists Cryo-Cell helped compile to a competitor.

In December 2004, a federal judge in Delaware reversed the last remaining aspect of a $7.1 million judgment from October 2003 for patent infringement against several of the nation's largest umbilical-cord blood banks.

In August, 2011, Mr. Portnoy led a group in a winning proxy fight which resulted in the replacement of the company's board of directors.